Complement Studies in Membrano-proliferative Glomerulonephritis

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1972 Jul 1

PMID 4625395

Citations 38

Authors

D K PETERS

A Martin

A Weinstein

J S Cameron

T M BARRATT

C S Ogg

P J LACHMANN

Affiliations

Soon will be listed here.

Citing Articles

Genetic investigation of Nordic patients with complement-mediated kidney diseases.

Rydberg V, Aradottir S, Kristoffersson A, Svitacheva N, Karpman D Front Immunol. 2023; 14:1254759.

PMID: 37744338 PMC: 10513385. DOI: 10.3389/fimmu.2023.1254759.

Challenges in diagnostic testing of nephritic factors.

Michels M, Volokhina E, van de Kar N, van den Heuvel L Front Immunol. 2022; 13:1036136.

PMID: 36451820 PMC: 9702996. DOI: 10.3389/fimmu.2022.1036136.

Physiology and pathology of the C3 amplification cycle: A retrospective.

Peters K Immunol Rev. 2022; 313(1):217-224.

PMID: 36408746 PMC: 10099761. DOI: 10.1111/imr.13165.

Interpretation of Serological Complement Biomarkers in Disease.

Ekdahl K, Persson B, Mohlin C, Sandholm K, Skattum L, Nilsson B Front Immunol. 2018; 9:2237.

PMID: 30405598 PMC: 6207586. DOI: 10.3389/fimmu.2018.02237.

Complement diagnostics: concepts, indications, and practical guidelines.

Nilsson B, Nilsson Ekdahl K Clin Dev Immunol. 2012; 2012:962702.

PMID: 23227092 PMC: 3511841. DOI: 10.1155/2012/962702.

References

Haupt H, Heide K . [Isolation and properties of a beta-glycoprotein from human serum]. Clin Chim Acta. 1965; 12(4):419-24. DOI: 10.1016/0009-8981(65)90130-0. View

Alper C, Rosen F . Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest. 1967; 46(12):2021-34. PMC: 292954. DOI: 10.1172/JCI105691. View

MULLER-EBERHARD H . Chemistry and reaction mechanisms of complement. Adv Immunol. 1968; 8:1-80. DOI: 10.1016/s0065-2776(08)60464-2. View

Spitzer R, Vallota E, Forristal J, Sudora E, Stitzel A, Davis N . Serum C'3 lytic system in patients with glomerulonephritis. Science. 1969; 164(3878):436-7. DOI: 10.1126/science.164.3878.436. View

Bokisch V, MULLER-EBERHARD H, Cochrane C . Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med. 1969; 129(5):1109-30. PMC: 2138643. DOI: 10.1084/jem.129.5.1109. View

Pickering R, Wolfson M, GOOD R, Gewurz H . Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement. Proc Natl Acad Sci U S A. 1969; 62(2):521-7. PMC: 277829. DOI: 10.1073/pnas.62.2.521. View

Gewurz H, Pickering R, NAFF G, Snyderman R, Mergenhagen S, GOOD R . Decreased properdin activity in acute glomerulonephritis. Int Arch Allergy Appl Immunol. 1969; 36(6):592-8. DOI: 10.1159/000230780. View

Oliveira B, OSLER A, Siraganian R, Sandberg A . The biologic activities of guinea pig antibodies. I. Separation of gamma1 and gamma2 immunoglobulins and their participation in allergic reactions of the immediate type. J Immunol. 1970; 104(2):320-8. View

Sandberg A, OSLER A, Shin H, Oliveira B . The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins. J Immunol. 1970; 104(2):329-34. View

10.

Pickering R, Herdman R, Michael A, Vernier R, Gewurz H, Fish A . Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis). Medicine (Baltimore). 1970; 49(3):207-26. DOI: 10.1097/00005792-197005000-00002. View

11.

Vallota E, Forristal J, Spitzer R, Davis N, WEST C . Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum. J Exp Med. 1970; 131(6):1306-24. PMC: 2138838. DOI: 10.1084/jem.131.6.1306. View

12.

Thompson R, LACHMANN P . Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J Exp Med. 1970; 131(4):629-41. PMC: 2138783. DOI: 10.1084/jem.131.4.629. View

13.

LACHMANN P, Thompson R . Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med. 1970; 131(4):643-57. PMC: 2138770. DOI: 10.1084/jem.131.4.643. View

14.

Gewurz H, Pickering R, Snyderman R, Lichtenstein L, GOOD R, Mergenhagen S . Interactions of the complement system with endotoxic lipopolysaccharides in immunoglobulin-deficient sera. J Exp Med. 1970; 131(4):817-31. PMC: 2138773. DOI: 10.1084/jem.131.4.817. View

15.

Churg J, Habib R, White R . Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet. 1970; 760(1):1299-302. DOI: 10.1016/s0140-6736(70)91905-7. View

16.

Cameron J, GLASGOW E, Ogg C, White R . Membranoproliferative glomerulonephritis and persistent hypocomplementaemia. Br Med J. 1970; 4(5726):7-14. PMC: 1820529. DOI: 10.1136/bmj.4.5726.7. View

17.

BOENISCH T, Alper C . Isolation and properties of a glycine-rich beta-glycoprotein of human serum. Biochim Biophys Acta. 1970; 221(3):529-35. DOI: 10.1016/0005-2795(70)90224-2. View

18.

Westberg N, Naff G, Boyer J, Michael A . Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia. J Clin Invest. 1971; 50(3):642-9. PMC: 291972. DOI: 10.1172/JCI106534. View

19.

Tedesco F, LACHMANN P . The quantitation of C6 in rabbit and human sera. Clin Exp Immunol. 1971; 9(3):359-70. PMC: 1713081. View

20.

Thompson R . C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis. Immunology. 1972; 22(1):147-58. PMC: 1408205. View